The Food and Drug Administration, facing increased criticism of its regulatory process for gene-edited animals, is mounting a new effort to defend its policies to farmers, researchers and developers, ...
As pharmaceutical manufacturing grows increasingly complex, Merck KGaA wants to ramp up its development capabilities for clinical trial compounds. The German life sciences company got one step closer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results